🇺🇸 FDA
Pipeline program

Tranexamic Acid

ShanghaiFMIH-TXA1

Approved small_molecule active

Quick answer

Tranexamic Acid for Postpartum Hemorrhage, Cesarean Section is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Postpartum Hemorrhage, Cesarean Section
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials